60 Degrees Pharmaceuticals, Inc.
SXTP
$4.62
-$0.42-8.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 528.60K | 307.90K | 256.30K | 261.40K | 148.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 528.60K | 307.90K | 256.30K | 261.40K | 148.10K |
| Cost of Revenue | 537.70K | 299.90K | 480.90K | -1.03M | 711.70K |
| Gross Profit | -9.10K | 7.90K | -224.60K | 1.29M | -563.60K |
| SG&A Expenses | 1.51M | 1.61M | 1.69M | 1.61M | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.85M | 1.91M | 2.17M | 2.34M | 2.27M |
| Operating Income | -2.33M | -1.60M | -1.91M | -2.08M | -2.12M |
| Income Before Tax | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M |
| Income Tax Expenses | 300.00 | 1.50K | 100.00 | -500.00 | 300.00 |
| Earnings from Continuing Operations | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 700.00 | 1.20K | 800.00 | 3.90K | 700.00 |
| Net Income | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M |
| EBIT | -2.33M | -1.60M | -1.91M | -2.08M | -2.12M |
| EBITDA | -2.30M | -1.59M | -1.89M | -2.06M | -2.10M |
| EPS Basic | -2.66 | -5.05 | -6.22 | -9.11 | -18.63 |
| Normalized Basic EPS | -1.58 | -2.94 | -3.65 | -5.34 | -11.05 |
| EPS Diluted | -2.66 | -5.05 | -6.22 | -9.11 | -18.63 |
| Normalized Diluted EPS | -1.58 | -2.94 | -3.65 | -5.34 | -11.05 |
| Average Basic Shares Outstanding | 918.90K | 368.20K | 320.90K | 238.90K | 122.20K |
| Average Diluted Shares Outstanding | 918.90K | 368.20K | 320.90K | 238.90K | 122.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |